What is Synthpop?
Synthpop was founded with a mission to streamline healthcare operations and elevate patient care through advanced artificial intelligence. The company develops AI-driven solutions designed to alleviate the administrative burden on healthcare professionals, enabling them to dedicate more time to critical responsibilities that directly benefit their organizations and patients. By focusing on the intersection of technology and human-centric care, Synthpop aims to redefine efficiency and personalization within the healthcare industry.
How much funding has Synthpop raised?
Synthpop has raised a total of $38.2M across 3 funding rounds:
Angel/Seed
$8.2M
Private Equity
$15M
Series A
$15M
Angel/Seed (2024): $8.2M with participation from Flexcap, Newfund, Captra Capital, Zelda Ventures, Peterson Ventures, Page One Ventures, OVO Fund, Think + Ventures, and Defy
Private Equity (2025): $15M, investors not publicly disclosed
Series A (2026): $15M supported by Defy, Ansa Capital, and Peterson Ventures
Key Investors in Synthpop
Flexcap
Flexcap Ventures Management operates as an investment management firm focused on identifying and capitalizing on compelling opportunities across multiple sectors. The company combines rigorous analytical frameworks with hands-on investment expertise to build diversified portfolios that generate sustainable returns for its investors.
Newfund
Newfund Capital is an early-stage venture capital firm based in Silicon Valley and Paris, dedicated to investing in exceptional entrepreneurs. The firm focuses on helping startups grow by providing opportunities for scaling, networking, and success while prioritizing investments that benefit both people and the planet.
Captra Capital
Captra Capital is a groundbreaking infrastructure investment firm dedicated to building long-term value for our investors and developing innovative solutions to help communities prosper. With a solid foundation built on predictable revenues and strong potential for substantial future growth, Captra creates truly exceptional opportunities for institutional and private investors to deploy capital.
What's next for Synthpop?
The recent major strategic investment, classified as a Series A round, indicates Synthpop is poised for significant scaling and market expansion. This capital will likely be deployed to further develop its AI technologies, broaden its service offerings, and strengthen its market presence. The company's focus on operational efficiency and personalized patient care positions it well to address key challenges within the healthcare sector, suggesting a future focused on innovation and strategic partnerships to drive growth and impact.
See full Synthpop company page
